Gastrointestinal Over-The-Counter (OTC) Drugs Market Report 2026
Download Free Sample Buy Now
Gastrointestinal Over-The-Counter (OTC) Drugs Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Gastrointestinal Over-The-Counter (OTC) Drugs Market Report 2026

Global Outlook – By Product (Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products), By Formulation (Tablets, Capsules, Liquids, Other Formulations), By Indications (Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-Users (Hospitals, Clinics, Home Healthcare, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

• Gastrointestinal Over-The-Counter (OTC) Drugs market size has reached to $49.59 billion in 2025

• Expected to grow to $73.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%

• Growth Driver: The Increasing Prevalence Of Digestive Disorders Is Fueling The Growth Of The Market Due To Growing Digestive Health Concerns

• Market Trend: Advancements In OTC Gastrointestinal Drugs For Long-Lasting Acid Relief

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gastrointestinal Over-The-Counter (OTC) Drugs Market?

Gastrointestinal over-the-counter (OTC) drugs are medications available without a prescription to prevent or treat common digestive system problems. They offer fast and easy relief for issues such as indigestion and irregular bowel movements to effectively manage mild to moderate digestive discomfort and support overall digestive wellness safely and conveniently.

The main products of gastrointestinal OTC drugs are antacids, laxatives, anti-diarrheals, anti-emetics, and others. Antacids are medications that neutralize stomach acid to relieve heartburn and indigestion. It is available in various formulations, such as tablets, capsules, liquids, and others, for several indications, including heartburn, diarrhea, constipation, gastroesophageal reflux disease (GERD), nausea, vomiting, motion sickness, and others. It is distributed through various distribution channels, such as direct tender, hospital pharmacy, retail pharmacy, online pharmacy, and others, and used by several key end-users, including hospitals, clinics, home healthcare, and others.

Gastrointestinal Over-The-Counter (OTC) Drugs Market Global Report 2026 Market Report bar graph

What Is The Gastrointestinal Over-The-Counter (OTC) Drugs Market Size and Share 2026?

The gastrointestinal over-the-counter (otc) drugs market size has grown strongly in recent years. It will grow from $49.59 billion in 2025 to $53.74 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to digestive disorder prevalence, otc drug accessibility, pharmacy retail expansion, urban lifestyle changes, dietary habit shifts.

What Is The Gastrointestinal Over-The-Counter (OTC) Drugs Market Growth Forecast?

The gastrointestinal over-the-counter (otc) drugs market size is expected to see strong growth in the next few years. It will grow to $73.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to preventive digestive care adoption, e-commerce growth, clean-label otc demand, aging population, digestive health awareness. Major trends in the forecast period include rising self-medication for digestive disorders, growing demand for fast-acting otc relief, increased use of combination gastrointestinal products, expansion of online pharmacy sales, growing preference for herbal and enzyme-based products.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Segmentation

1) By Product: Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products

2) By Formulation: Tablets, Capsules, Liquids, Other Formulations

3) By Indications: Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Clinics, Home Healthcare, Other End-Users

Subsegments:

1) By Antacid: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Calcium Carbonate, Magnesium Hydroxide, Sodium Bicarbonate, Combination Antacids

2) By Laxatives: Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxatives, Stool Softeners, Lubricant Laxatives

3) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Probiotics, Electrolyte Solutions

4) By Anti-Emetics: Antihistamines, Bismuth Subsalicylate, Phosphorated Carbohydrate Solution, Ginger Supplements

5) By Other Products: Digestive Enzymes, Simethicone, Herbal Remedies, Activated Charcoal

What Is The Driver Of The Gastrointestinal Over-The-Counter (OTC) Drugs Market?

The increasing prevalence of digestive disorders is expected to propel the growth of the gastrointestinal OTC drugs market going forward. Digestive disorders refer to a range of conditions that affect the gastrointestinal tract, including the stomach, intestines, and associated organs. The rise in digestive disorders is mainly due to higher intake of processed, low-fiber foods, which disrupt gut health and impair digestion. Gastrointestinal OTC drugs ease digestive disorder symptoms by reducing stomach acid, regulating bowel movements, and enhancing gut health. They provide fast, convenient relief from common issues like acidity, constipation, and indigestion. For instance, in December 2023, according to the IBD Registry Ltd., a UK-based non-profit organization, the number of individuals with inflammatory bowel disease (IBD) reached over 5,300, marking an increase of more than 3,000 members compared to 2022. Therefore, the increasing prevalence of digestive disorders is driving the growth of the gastrointestinal OTC drugs market.

Key Players In The Global Gastrointestinal Over-The-Counter (OTC) Drugs Market

Major companies operating in the gastrointestinal over-the-counter (otc) drugs market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd.

Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Trends and Insights

Major companies operating in the gastrointestinal OTC drugs market are focusing on developing advanced products, such as OTC proton pump inhibitors, to provide effective and long-lasting relief from acid-related disorders. Over-the-counter (OTC) proton pump inhibitors (PPIs) are a class of medications available without a prescription that reduce the production of stomach acid. They are commonly used to treat conditions such as frequent heartburn, acid reflux (GERD), and gastric ulcers. For instance, in March 2025, Eisai Co., Ltd., a Japan-based pharmaceutical company, received approval in Japan to switch its Pariet S (rabeprazole sodium 10 mg) from prescription (RX) to over-the-counter (OTC) status, making it the first OTC PPI in Japan containing the same active ingredient and dosage as the prescription product. Pariet S is indicated for stomach pain, heartburn, and bloating, offering 24-hour relief with a once-daily, easy-to-swallow tablet, and aims to address the growing need for effective gastric acid-related treatments due to lifestyle and demographic changes.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Gastrointestinal Over-The-Counter (OTC) Drugs Market?

In July 2024, Cooper Consumer Health SAS, a France-based consumer healthcare company, acquired Viatris Inc.’s Over-the-Counter (OTC) business for an undisclosed amount. With this acquisition, Cooper Consumer Health aims to double its revenues and scale its presence across key European markets by adding over 200 renowned OTC brands in therapeutic areas such as feminine hygiene, antiseptics, and cholesterol reduction. Viatris Inc. is a US-based healthcare company that specializes in providing gastrointestinal over-the-counter (OTC) drugs.

Regional Insights

North America was the largest region in the gastrointestinal over-the-counter (OTC) drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastrointestinal Over-The-Counter (OTC) Drugs Market?

The gastrointestinal over-the-counter (OTC) drugs market consists of sales of digestive enzymes, probiotics, stool softeners, and fiber supplements. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastrointestinal Over-The-Counter (OTC) Drugs Market Report 2026?

The gastrointestinal over-the-counter (otc) drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal over-the-counter (otc) drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Gastrointestinal Over-The-Counter (OTC) Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $53.74 billion
Revenue Forecast In 2035 $73.3 billion
Growth Rate CAGR of 8.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Formulation, Indications, Distribution Channel, End-Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Ben
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gastrointestinal Over-The-Counter (OTC) Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gastrointestinal Over-The-Counter (OTC) Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Digitalization, Cloud, Big Data & Cybersecurity

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Sustainability, Climate Tech & Circular Economy

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Rising Self-Medication For Digestive Disorders

4.2.2 Growing Demand For Fast-Acting Otc Relief

4.2.3 Increased Use Of Combination Gastrointestinal Products

4.2.4 Expansion Of Online Pharmacy Sales

4.2.5 Growing Preference For Herbal And Enzyme-Based Products

5. Gastrointestinal Over-The-Counter (OTC) Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Home Healthcare

5.4 Retail Pharmacies

5.5 Online Consumers

6. Gastrointestinal Over-The-Counter (OTC) Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastrointestinal Over-The-Counter (OTC) Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gastrointestinal Over-The-Counter (OTC) Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastrointestinal Over-The-Counter (OTC) Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastrointestinal Over-The-Counter (OTC) Drugs Market Segmentation

9.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products

9.2. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tablets, Capsules, Liquids, Other Formulations

9.3. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications

9.4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

9.5. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Home Healthcare, Other End-Users

9.6. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Antacid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Calcium Carbonate, Magnesium Hydroxide, Sodium Bicarbonate, Combination Antacids

9.7. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxatives, Stool Softeners, Lubricant Laxatives

9.8. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Diarrheal, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Loperamide, Bismuth Subsalicylate, Probiotics, Electrolyte Solutions

9.9. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Emetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antihistamines, Bismuth Subsalicylate, Phosphorated Carbohydrate Solution, Ginger Supplements

9.10. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Digestive Enzymes, Simethicone, Herbal Remedies, Activated Charcoal

10. Gastrointestinal Over-The-Counter (OTC) Drugs Market Regional And Country Analysis

10.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market

11.1. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastrointestinal Over-The-Counter (OTC) Drugs Market

12.1. China Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastrointestinal Over-The-Counter (OTC) Drugs Market

13.1. India Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market

14.1. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market

15.1. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market

16.1. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market

17.1. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastrointestinal Over-The-Counter (OTC) Drugs Market

18.1. Taiwan Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastrointestinal Over-The-Counter (OTC) Drugs Market

19.1. South East Asia Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market

20.1. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market

21.1. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market

22.1. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastrointestinal Over-The-Counter (OTC) Drugs Market

23.1. France Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market

24.1. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market

25.1. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market

26.1. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market

27.1. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market

28.1. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market

29.1. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market

30.1. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market

31.1. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market

32.1. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market

33.1. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market

34.1. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Segmentation By Formulation, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastrointestinal Over-The-Counter (OTC) Drugs Market Regulatory and Investment Landscape

36. Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Landscape And Company Profiles

36.1. Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gastrointestinal Over-The-Counter (OTC) Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gastrointestinal Over-The-Counter (OTC) Drugs Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Procter & Gamble Co. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Gastrointestinal Over-The-Counter (OTC) Drugs Market Other Major And Innovative Companies

Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd.

38. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastrointestinal Over-The-Counter (OTC) Drugs Market

40. Gastrointestinal Over-The-Counter (OTC) Drugs Market High Potential Countries, Segments and Strategies

40.1 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Overview Of Key Products - Product Examples
  • Table 2: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Supply Chain Analysis
  • Table 4: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Major Raw Material Providers
  • Table 5: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Major Resource Providers
  • Table 6: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Major Manufacturers (Suppliers)
  • Table 7: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Major Distributors And Channel Partners
  • Table 8: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Key Technologies & Future Trends
  • Table 9: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Major Trends
  • Table 10: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Major End Users
  • Table 11: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Gastrointestinal Over-The-Counter (OTC) Drugs Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Gastrointestinal Over-The-Counter (OTC) Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market - TAM, US$ Billion, 2025
  • Table 15: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Antacid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Diarrheal, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Emetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global Gastrointestinal Over-The-Counter (OTC) Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market - Company Scoring Matrix
  • Table 101: Pfizer Inc. Financial Performance
  • Table 102: Procter & Gamble Co. Financial Performance
  • Table 103: Johnson & Johnson Financial Performance
  • Table 104: Merck & Co. Inc. Financial Performance
  • Table 105: Bayer AG Financial Performance
  • Table 106: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Competitive Dashboard
  • Table 108: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, Gastrointestinal Over-The-Counter (OTC) Drugs Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 110: Global, Gastrointestinal Over-The-Counter (OTC) Drugs Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Table 111: Global, Gastrointestinal Over-The-Counter (OTC) Drugs Market Size Gain ($ Billion), Segmentation By Indications, 2025 – 2030

List Of Figures

    Figure 1: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Supply Chain Analysis
  • Figure 4: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Major Raw Material Providers
  • Figure 5: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Major Resource Providers
  • Figure 6: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Major Distributors And Channel Partners
  • Figure 8: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Key Technologies & Future Trends
  • Figure 9: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Major Trends
  • Figure 10: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Major End Users
  • Figure 11: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Gastrointestinal Over-The-Counter (OTC) Drugs Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Gastrointestinal Over-The-Counter (OTC) Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market - TAM, US$ Billion, 2025
  • Figure 15: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Antacid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Diarrheal, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Emetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global Gastrointestinal Over-The-Counter (OTC) Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market - Company Scoring Matrix
  • Figure 101: Pfizer Inc. Financial Performance
  • Figure 102: Procter & Gamble Co. Financial Performance
  • Figure 103: Johnson & Johnson Financial Performance
  • Figure 104: Merck & Co. Inc. Financial Performance
  • Figure 105: Bayer AG Financial Performance
  • Figure 106: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Competitive Dashboard
  • Figure 108: Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, Gastrointestinal Over-The-Counter (OTC) Drugs Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 110: Global, Gastrointestinal Over-The-Counter (OTC) Drugs Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Figure 111: Global, Gastrointestinal Over-The-Counter (OTC) Drugs Market Size Gain ($ Billion), Segmentation By Indications, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retai...

Digestive Health Supplements Market Report 2026 - Global Outlook – By Product (Prebiotics, Probiotics, Enzymes, Other Product), By Form (Capsules, Tablets, Powders, Liquids, Other Form), By Distribution Channel (Supermar...

Dermatology OTC Medications Market Report 2026 - Global Outlook – By Type (Tablets And Capsules, Oils Gels, Creams And Ointments, Other Types), By Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Anti-Fungal, War...

Gastric Cancer Drugs Market Report 2026 - Global Outlook – By Type (Imatinib, Trastuzumab, Other Types), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Clinics, Cancer Speciality Centers) – Market...

Otic Drugs Market Report 2026 - Global Outlook – By Drug Class (Cerumenolytics, Otic Anesthetics, Otic Anti-Infectives, Otic Steroids, Other Drug Class), By Indication (Otitis, Middle Ear Infections, Other Indication), B...

Colorectal Cancer Drugs Market Report 2026 - Global Outlook – By Type (Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1 Or PD1 Liga...

OTC Drug And Dietary Supplement Market Report 2026 - Global Outlook – By Category (Vitamin And Dietary Supplements, Cough And Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers...

Gastroparesis Drugs Market Report 2026 - Global Outlook – By Drug Type (Over-the-counter (OTC) Drugs, Prescription Drugs), By Drug Class (Prokinetic Agents, Antiemetic Drugs, Proton Pump Inhibitors, Other Drug Classes), ...

Frequently Asked Questions

The Gastrointestinal Over-The-Counter (OTC) Drugs market was valued at $49.59 billion in 2025, increased to $53.74 billion in 2026, and is projected to reach $73.3 billion by 2030.

The global Gastrointestinal Over-The-Counter (OTC) Drugs market is expected to grow at a CAGR of 8.1% from 2026 to 2035 to reach $73.3 billion by 2035.

Some Key Players in the Gastrointestinal Over-The-Counter (OTC) Drugs market Include, Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd. .

Major trend in this market includes: Advancements In OTC Gastrointestinal Drugs For Long-Lasting Acid Relief. For further insights on this market. request a sample here

North America was the largest region in the gastrointestinal over-the-counter (OTC) drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal over-the-counter (otc) drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us